id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1524-1369,FDA,FDA-2013-N-1524,Attachments G through H Catalyst Pharmaceutical Partners Inc. Press Releases re Request for Nomination from Catalyst Pharmaceutical Partners Inc.,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T17:09:43Z,,0,0,090000648191ccb6
FDA-2013-N-1524-1367,FDA,FDA-2013-N-1524,Attachment B Aminopyridine Review FDA Compounding Advisory Committee General Comments re Request for Nomination from Catalyst Pharmaceutical Partners Inc.,Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T17:03:27Z,,0,0,090000648191cc1b
FDA-2013-N-1524-1366,FDA,FDA-2013-N-1524,"Attachment A Pharmacy Compounding Advisory Committee Meetng Minutes May 6 and 7, 1999 re Request for Nomination from Catalyst Pharmaceutical Partners Inc.",Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T17:02:10Z,,0,0,090000648191cc19
FDA-2013-N-1524-1368,FDA,FDA-2013-N-1524,"Attachment C May 6, 1999 Pharmacy Compounding Advisory Committee Meeting re Request for Nomination from Catalyst Pharmaceutical Partners Inc.",Supporting & Related Material,Background Material,2014-11-10T05:00:00Z,2014,11,,,2014-11-10T17:04:46Z,,0,0,090000648191cc1d
FDA-2013-N-1524-0682,FDA,FDA-2013-N-1524,"Letter from Gary Gray to California State Board of Pharmacy Dated August 18, 2014 RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX",Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-10-06T17:53:32Z,,0,0,090000648185e5e6
FDA-2013-N-1524-0683,FDA,FDA-2013-N-1524,National Plan to Address Alzheimer's Disease RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX,Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-09-17T00:00:36Z,,0,0,090000648185e5e7
FDA-2013-N-1524-0685,FDA,FDA-2013-N-1524,Summary of  Pharmaclogical Drug Information RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX,Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-09-17T00:11:08Z,,0,0,090000648185e5ea
FDA-2013-N-1524-0687,FDA,FDA-2013-N-1524,"Cited Reference Martin-Moreno et al Prolonged Oral Cannabinoid Administration Prevents Neuroinflammation Lowers b-amyloid
Levels and Improves Cognitive Performance in Tg APP 2576 mice RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX",Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-10-06T18:21:28Z,,0,0,090000648185e5f6
FDA-2013-N-1524-0688,FDA,FDA-2013-N-1524,Business Plan and Credentials from Gary Gray dba Complex RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX,Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-10-06T18:24:27Z,,0,0,090000648185e5f7
FDA-2013-N-1524-0686,FDA,FDA-2013-N-1524,"Letter from Gary Gray to DEA DOJ Dated August 12, 2014 RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX",Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-09-17T00:10:44Z,,0,0,090000648185e5eb
FDA-2013-N-1524-0684,FDA,FDA-2013-N-1524,California State Board of Pharmacy Community Pharmacy Permit Application from Gary Gray RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX,Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-09-17T00:07:06Z,,0,0,090000648185e5e8
FDA-2013-N-1524-0690,FDA,FDA-2013-N-1524,503A Pharmacy Compounded Drug Product Nomination July 2014 Guidance CDER at FDA RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX,Supporting & Related Material,Background Material,2014-09-16T04:00:00Z,2014,9,,,2014-09-17T00:20:16Z,,0,0,090000648185e5fa
FDA-2013-N-1524-0680,FDA,FDA-2013-N-1524,"Cited Reference The Endocannabinoid System as an Emerging Target
of Pharmacotherapy Pacher et al RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX",Supporting & Related Material,Background Material,2014-09-15T04:00:00Z,2014,9,,,2014-09-17T00:28:46Z,,0,0,090000648185e5e9
FDA-2013-N-1524-0298,FDA,FDA-2013-N-1524,"Bulk Drug Substances That May Be Used To Compound Drug Products in
Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act, Concerning Outsourcing Facilities; Revised Request for Nominations",Notice,Request for Nominations,2014-07-02T04:00:00Z,2014,7,2014-07-02T04:00:00Z,2014-10-01T03:59:59Z,2015-07-23T01:30:24Z,2014-15373,0,0,090000648178723a